Correction to: Resolution of Persistent COVID-19 After Convalescent Plasma in a Patient with B Cell Aplasia

Affiliations

¹ University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
² University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. a.m.shields@bham.ac.uk.
³ Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK. a.m.shields@bham.ac.uk.
⁴ Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
⁵ Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.

Published Erratum

Emily McKemey et al. J Clin Immunol. 2021 Jul.

. 2021 Jul;41(5):930.

doi: 10.1007/s10875-021-01029-z.

¹ University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
² University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. a.m.shields@bham.ac.uk.
³ Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK. a.m.shields@bham.ac.uk.
⁴ Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
⁵ Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.

No abstract available

Erratum for

Resolution of Persistent COVID-19 After Convalescent Plasma in a Patient with B Cell Aplasia.
McKemey E, Shields AM, Faustini SE, Hill HJ, Barnskaya A, Stamataki Z, Gompertz S, Richter AG, Dosanjh D, Madathil S. McKemey E, et al. J Clin Immunol. 2021 Jul;41(5):926-929. doi: 10.1007/s10875-021-00996-7. Epub 2021 Feb 20. J Clin Immunol. 2021. PMID: 33611660 Free PMC article. No abstract available.